Salk Institute's Tony Hunter wins 2018 Tang Prize in Biopharmaceutical Science
Share

IMAGE: This is Salk Professor Tony Hunter. view more 

Credit: Salk Institute

LA JOLLA–(June 19, 2018) Salk American Cancer Society Professor Tony Hunter has been awarded the 2018 Tang Prize in Biopharmaceutical Science.

Hunter will share the prize of $50 million Taiwanese dollars (approximately $1.5 million US) equally with fellow cancer researchers Brian Druker and John Mendelsohn, who also share with Hunter a connection to UC San Diego. Hunter is a longtime adjunct professor at the university, Druker was an undergraduate and medical student there, and Mendelsohn was founding director of the UCSD Cancer Center.

The four biennial Tang Prize categories recognize and encourage original research and major contributions in biopharmaceutical science, sustainable development, sinology and law. The prize ceremony will be held in Taipei, Taiwan, on September 21, 2018, as part of a weeklong series of events that includes a laureate lecture and a question-and-answer forum with students.

“Although he is far too humble to think in these terms, Tony’s seminal discovery in 1979 of a molecular switch for cancer was a defining moment for a thoroughly new era of life-saving cancer therapies,” says Salk President Rusty Gage. “His body of work is a testament to the importance

read more...


Article originally posted at
www.eurekalert.org

Click here for the full story


CategoryAggregator News

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD